— Know what they know.
Not Investment Advice
Also trades as: 0JDB.L (LSE) · $vol 0M · NVTAQ (OTC) · $vol 0M

NVTA NYSE

Invitae Corporation
1W: -3.6% 1M: -11.1% 3M: -97.2% 1Y: -99.0% 3Y: -100.0% 5Y: -99.9%
$0.02
Last traded 2024-03-11 — delisted
NYSE · Healthcare · Medical - Diagnostics & Research · $5.4M mcap · 284M float · 4.52% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$516M +12.1% ▲
5Y CAGR: +49.9%
Gross Profit
$99M -11.4% ▼
5Y CAGR: +40.5%
Operating Income
-$714M +8.2% ▲
Net Income
-$3.1B -719.6% ▼
EPS (Diluted)
$-13.18 -632.2% ▼
EBITDA
-$2.9B -696.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$148M$217M$280M$460M$516M
YoY Growth+116.5%+46.8%+29.0%+64.7%+12.1%
Cost of Revenue$80M$118M$198M$349M$417M
Gross Profit$68M$99M$81M$112M$99M
Gross Margin45.8%45.5%29.1%24.3%19.2%
R&D Expenses$63M$142M$241M$416M$402M
SG&A Expenses$127M$201M$493M$474M$411M
Operating Expenses$190M$343M$733M$890M$813M
Operating Income-$123M-$244M-$652M-$778M-$714M
Operating Margin-83.0%-112.6%-233.3%-169.0%-138.3%
Interest Expense$7M$12M$30M$50M$57M
Income Before Tax-$132M-$260M-$714M-$416M-$3.2B
Tax Expense-$3M-$18M-$105M-$37M-$45M
Net Income-$129M-$242M-$609M-$379M-$3.1B
Net Margin-87.6%-111.6%-217.8%-82.3%-601.6%
EPS (Diluted)$-1.94$-2.66$-4.52$-1.80$-13.18
EBITDA-$112M-$236M-$678M-$392M-$2.9B
Shares Outstanding67M91M135M211M236M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms